Drug intelligence / Profile preview

metoprolol + morphine

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Intramuscular, Intrathecal, Intravenous, Oral, Rectal, Subcutaneous
01

Overview

Metoprolol + morphine is a combination of two pharmaceutical drugs, each with distinct mechanisms and indications. Metoprolol is a cardioselective beta-blocker that acts primarily as an antagonist at the beta-1 adrenergic receptor in cardiac tissue, reducing heart rate, contractility, and blood pressure. It is indicated for hypertension, angina pectoris, heart failure, myocardial infarction recovery, atrial fibrillation/flutter, and other cardiovascular conditions[2][3][6]. Morphine is an opioid analgesic that acts as an agonist at mu-, kappa-, and delta-opioid receptors in the central nervous system to relieve moderate to severe pain[8]. The combination may be used in clinical settings where both cardiovascular management (metoprolol) and pain control (morphine) are required; however, co-administration can result in additive effects on lowering blood pressure and should be monitored closely due to risk of hypotension or bradycardia[1][5].

Other names
metoprolol tartratemetoprolol succinatemorphine sulfate
02

Targets

DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)ADRB1 (β1)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on metoprolol + morphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metoprolol + morphine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call